NCT00707356: Study of WST11 in Patients With Localized Prostate Cancer
- State
- Completed
- Phase
- Phase 2
- People
- 42 taking part
- Started
- Sep 2008
- Primary completion
- Jan 2011
- Arms
- WST11(TOOKAD® Soluble)
- Results
- None posted
- 30 Jun 2008: Trial registered
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Trial registered. A trial in people is registered. As of 19 Nov 2026, from 5 registered trials.
Kind of treatment: Drug.
Also known as TOOKAD Soluble 4 mg/kg, Tookad®, TOOKAD® Soluble, WST 11 -mediated -VTP.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.